{"status":"OK","data":{"id":2723730,"identifier":"DVN/EKISQY","persistentUrl":"https://doi.org/10.7910/DVN/EKISQY","protocol":"doi","authority":"10.7910","publisher":"Harvard Dataverse","publicationDate":"2016-03-10","storageIdentifier":"s3://dvn-cloud:10.7910/DVN/EKISQY","latestVersion":{"id":77862,"storageIdentifier":"s3://dvn-cloud:10.7910/DVN/EKISQY","versionNumber":1,"versionMinorNumber":0,"versionState":"RELEASED","productionDate":"Production Date","lastUpdateTime":"2016-03-10T09:17:38Z","releaseTime":"2016-03-10T09:17:38Z","createTime":"2015-11-10T10:15:41Z","license":"CC0","termsOfUse":"CC0 Waiver","metadataBlocks":{"citation":{"displayName":"Citation Metadata","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"Labcode 7- HIV neutralization Protocol PBMC Neutralization assay"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Hanneke Schuitemaker;"},"authorAffiliation":{"typeName":"authorAffiliation","multiple":false,"typeClass":"primitive","value":"Academic Medical Center, the Netherlands"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Hanneke Schuitemaker;"},"datasetContactAffiliation":{"typeName":"datasetContactAffiliation","multiple":false,"typeClass":"primitive","value":"Academic Medical Center, the Netherlands"},"datasetContactEmail":{"typeName":"datasetContactEmail","multiple":false,"typeClass":"primitive","value":"h.schuitemaker@amc.uva.nl"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"This document describes the isolation of Peripheral Blood Mononuclear Cells (PBMCs) from buffycoat, the stimulation of PBMCs by PHA, and the determination of the neutralization sensitivity of HIV-1 strains using a PBMC neutralization assay. Two different protocols are in use for the PBMC neutralization assay, depending on whether viruses are tested for sensitivity to a polyclonal (serum) or monoclonal (antibody) neutralizing agent."}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"sheik-khalil, enas"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2015-11-10"}]}},"files":[{"label":"Labcode 7- HIV neutralization Protocol PBMC Neutralization assay.pdf","restricted":false,"version":1,"datasetVersionId":77862,"dataFile":{"id":2723731,"persistentId":"doi:10.7910/DVN/EKISQY/5F0O1Q","pidURL":"https://doi.org/10.7910/DVN/EKISQY/5F0O1Q","filename":"Labcode 7- HIV neutralization Protocol PBMC Neutralization assay.pdf","contentType":"application/pdf","filesize":107017,"storageIdentifier":"s3://dvn-cloud:150f0e4caad-50798ba7b985","rootDataFileId":-1,"md5":"123acdfb6cdce736c59dc87e9141937f","checksum":{"type":"MD5","value":"123acdfb6cdce736c59dc87e9141937f"}}}]}}}